SEARCH

SEARCH BY CITATION

REFERENCES

  • Abecasis GR, Cherny SS, Cookson WO, Cardon LR. 2002. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30(1): 97101.
  • Arinami T, Ohtsuki T, Ishiguro H, Ujike H, Tanaka Y, Morita Y, et al. 2005. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet 77(6): 937944.
  • Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, et al. 1998. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20(1): 7073.
  • Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A, et al. 1997. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 43(1): 18.
  • Cardno AG, Jones LA, Murphy KC, Sanders RD, Asherson P, Owen MJ, et al. 1999a. Dimensions of psychosis in affected sibling pairs. Schizophr Bull 25(4): 841850.
  • Cardno AG, Bowen T, Guy CA, Jones LA, McCarthy G, Williams NM, et al. 1999b. CAG repeat length in the hKCa3 gene and symptom dimensions in schizophrenia. Biol Psychiatry 45(12): 15921596.
  • Cardno AG, Sham PC, Farmer AE, Murray RM, McGuffin P. 2002. Heritability of Schneider's first-rank symptoms. Br J Psychiatry 180: 3538.
  • Cheng R, Juo SH, Loth JE, Nee J, Iossifov I, Blumenthal R, et al. 2006. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry 11: 252260.
  • Chiu YF, McGrath JA, Thornquist MH, Wolyniec PS, Nestadt G, Swartz KL, et al. 2002. Genetic heterogeneity in schizophrenia II: Conditional analyses of affected schizophrenia sibling pairs provide evidence for an interaction between markers on chromosome 8p and 14q. Mol Psychiatry 7(6): 658664.
  • Cutting GR. 2005. Modifier genetics: Cystic fibrosis. Annu Rev Genomics Hum Genet 6: 237260.
  • DeRosse P, Funke B, Burdick KE, Lencz T, Ekholm JM, Kane JM, et al. 2006. Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry 163(3): 532534.
  • Dick DM, Foroud T, Flury L, Bowman ES, Miller MJ, Rau NL, et al. 2003. Genomewide linkage analyses of bipolar disorder: A new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am J Hum Genet 73(1): 107114.
  • Fallin MD, Lasseter VK, Wolyniec PS, McGrath JA, Nestadt G, Valle D, et al. 2003. Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet 73(3): 601611.
  • Fanous AH, Kendler KS. 2005. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: Searching for a framework. Mol Psychiatry 10(1): 613.
  • Fanous AH, Neale MC, Straub RE, Webb BT, O'Neill AF, Walsh D, et al. 2004. Clinical features of psychotic disorders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: A family based association study. Am J Med Genet Part B 125B(1): 6978.
  • Fanous AH, Van Den Oord EJ, Riley BP, Aggen SH, Neale MC, O'Neill FA, et al. 2005. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry 162(10): 18241832.
  • Ferreira MA, O'gorman L, Le Souef P, Burton PR, Toelle BG, Robertson CF, et al. 2005. Robust estimation of experimentwise p values applied to a genome scan of multiple asthma traits identifies a new region of significant linkage on chromosome 20q13. Am J Hum Genet 77(6): 10751085.
  • Genin E, Clerget-Darpoux F. 1996. Consanguinity and the sib-pair method: An approach using identity by descent between and within individuals. Am J Hum Genet 59(5): 11491162.
  • Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, et al. 2001. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 68(3): 661673.
  • Kaiser R, Konneker M, Henneken M, Dettling M, Muller-Oerlinghausen B, Roots I, et al. 2000. Dopamine D4 receptor 48-bp repeat polymorphism: No association with response to antipsychotic treatment, but association with catatonic schizophrenia. Mol Psychiatry 5(4): 418424.
  • Kendler KS, O'Neill FA, Burke J, Murphy B, Duke F, Straub RE, et al. 1996a. Irish study on high-density schizophrenia families: Field methods and power to detect linkage. Am J Med Genet 67(2): 179190.
  • Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, et al. 1996b. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 153(12): 15341540.
  • Kendler KS, Karkowski-Shuman L, O'Neill FA, Straub RE, MacLean CJ, Walsh D. 1997. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: Evidence for possible etiologic heterogeneity. Am J Psychiatry 154(2): 191198.
  • Kendler KS, Myers JM, O'Neill FA, Martin R, Murphy B, MacLean CJ, et al. 2000;. Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 157(3): 402408.
  • Kong A, Cox NJ. 1997. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 61(5): 11791188.
  • Lander E, Kruglyak L. 1995. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11(3): 241247.
  • Levi A, Kohn Y, Kanyas K, Amann D, Pae CU, Hamdan A, et al. 2005. Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: Increased evidence for linkage and reduced linkage interval. Eur J Hum Genet 13(6): 763771.
  • Levinson DF, Mahtani MM, Nancarrow DJ, Brown DM, Kruglyak L, Kirby A, et al. 1998. Genome scan of schizophrenia. Am J Psychiatry 155(6): 741750.
  • Lindholm E, Ekholm B, Shaw S, Jalonen P, Johansson G, Pettersson U, et al. 2001. A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. Am J Hum Genet 69(1): 96105.
  • Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D. 1998. A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry 3(4): 328332.
  • Martin LJ, Comuzzie AG, Dupont S, Vionnet N, Dina C, Gallina S, et al. 2002. A quantitative trait locus influencing type 2 diabetes susceptibility maps to a region on 5q in an extended French family. Diabetes 51(12): 35683572.
  • Martinez M, Goldin LR, Cao Q, Zhang J, Sanders AR, Nancarrow DJ, et al. 1999. Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. Am J Med Genet 88(4): 337343.
  • McGuffin P, Farmer A, Harvey I. 1991. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48(8): 764770.
  • McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, et al. 2005. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet 77(4): 582595.
  • Middleton FA, Pato MT, Gentile KL, Morley CP, Zhao X, Eisener AF, et al. 2004. Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: A comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am J Hum Genet 74(5): 886897.
  • Mowry BJ, Ewen KR, Nancarrow DJ, Lennon DP, Nertney DA, Jones HL, et al. 2000. Second stage of a genome scan of schizophrenia: Study of five positive regions in an expanded sample. Am J Med Genet 96(6): 864869.
  • Muthen LK, Muthen BO. 2001. Mplus: Statistical analysis with latent variables: User's guide. Los Angeles: Muthen and Muthen.
  • Neale MC, Eaves LJ, Kendler KS. 1994. The power of the classical twin study to resolve variation in threshold traits. Behav Genet 24(3): 239258.
  • Paunio T, Ekelund J, Varilo T, Parker A, Hovatta I, Turunen JA, et al. 2001. Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum Mol Genet 10(26): 30373048.
  • Peralta V, Cuesta MJ. 2001. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res 49(3): 269285.
  • Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL, et al. 1995. Schizophrenia: A genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 60(3): 252260.
  • Roberts SB, MacLean CJ, Neale MC, Eaves LJ, Kendler KS. 1999. Replication of linkage studies of complex traits: An examination of variation in location estimates. Am J Hum Genet 65(3): 876884.
  • Schumacher J, Kaneva R, Jamra RA, Diaz GO, Ohlraun S, Milanova V, et al. 2005. Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24. Am J Hum Genet 77(6): 11021111.
  • Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M, et al. 1997. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 2(2): 156160.
  • Serretti A, Lattuada E, Lorenzi C, Lilli R, Smeraldi E. 2000. Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses. Mol Psychiatry 5(3): 270274.
  • Serretti A, Lilli R, Lorenzi C, Lattuada E, Smeraldi E. 2001. DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: A study on 2,011 affected subjects. Am J Med Genet 105(3): 283290.
  • Sklar P, Pato MT, Kirby A, Petryshen TL, Medeiros H, Carvalho C, et al. 2004. Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry 9(2): 213218.
  • Spitzer RL, Williams JB, Gibbon J. 1987. Structured Clinical Interview for DSM-III-R Patient Version.
  • Straub RE, Speer MC, Luo Y, Rojas K, Overhauser J, Ott J, et al. 1993. A microsatellite genetic linkage map of human chromosome 18. Genomics 15(1): 4856.
  • Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. 1997. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry 2(2): 148155.
  • Straub RE, Sullivan PF, Ma Y, Myakishev MV, Harris-Kerr C, Wormley B, et al. 1999. Susceptibility genes for nicotine dependence: A genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study. Mol Psychiatry 4(2): 129144.
  • Straub RE, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, et al. 2002. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiatry 7(6): 542559.
  • Weinberger DR. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44(7): 660669.
  • Williams NM, Rees MI, Holmans P, Norton N, Cardno AG, Jones LA, et al. 1999. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum Mol Genet 8(9): 17291739.
  • Zhang XY, Zhou DF, Zhang PY, Wei J. 2000. The CCK-A receptor gene possibly associated with positive symptoms of schizophrenia. Mol Psychiatry 5(3): 239240.